It is also noteworthy that evidence of a relationship between nitrated α-synuclein burden and enhanced protein transfer supports the development and evaluation of therapeutic strategies that, by targeting nitrated α-synuclein, could help counteract pathology propagation and disease progression in PD. This evidence concerns the gene SNCA and Parkinson disease.